Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

Entering 2025 having demonstrated rapid translation of genetic insights to positive clinical data; advancing clinically validated and multi-modal ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25Deepening responses observed over time in ...

Discover how genes define individuality, how new genes are created, and how evolution shapes our genome in 2024 research findings.

The relative humidity and temperature were adjusted according to ... Asian-Australasian Journal of Animal Sciences 2013;26:1665. Zhu LJ, Altmann SW. mRNA and 18S-RNA coapplicantion-reverse ...

The results are expressed as the mean ± SEM. The tissue weight, serum blood lipid levels, and mRNA expression were analysed using one-way ANOVA followed by Brown-Forsythe and Welch multiple ...

Mandy Cohen, director of the U.S. Centers for Disease Control and Prevention (CDC), pointed to mRNA as a preferred platform for the shot since vaccines can be developed and distributed quickly.

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada Michael Smith Laboratories, University of British Columbia, Vancouver, ...

However, Sema4A is also crucial for maintaining peripheral tissue homeostasis and its involvement in skin remains unknown. Here, we revealed that while Sema4A expression was pronounced in psoriatic ...